knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 22:10:53 - browse：1

Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble — coverage from STAT — Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble. Adobe

An early-stage clinical trial of a radiopharmaceutical drug developed by Johnson & Johnson showed some signs of efficacy in prostate cancer patients, newly released data show, but four participants in the trial died.

The drug, JNJ-6420, is designed to treat metastatic castration-resistant prostate cancer by delivering radioactive isotopes directly to cancer cells. Interest in such radiopharmaceuticals has skyrocketed following the approval of Pluvicto, which also treats prostate cancer.

In the Phase 1 data reported ahead of the American Society of Clinical Oncology meeting next week, 18% of participants on a mid-level dose of Johnson & Johnson’s treatment had a complete or partial response. For comparison, approximately 29.8% of the subjects in a Phase 3 trial of Pluvicto responded to the treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Timeline: Special counsel's probe into Trump's handling of classified documents

focus

WSS

An outrageous hospital charge: I paid $710 for an hour of babysitting

What the US credit downgrade means for the economy, your finances

Hospitals, health systems can help patients avoid medical debt

CDC: Cases of alpha

As the dark side of IVF slowly comes into focus, even more transparency is needed

Ford recalls 870K F

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Physician groups backed by private equity giant lobby on mergers

Trump demands the U.S. pay no more for drugs than other countries … again

VC firm RA Capital starts a new synthetic biology incubator

Trump demands the U.S. pay no more for drugs than other countries … again

Trump allegedly attempted to have surveillance video deleted: Special Counsel

After affirmative action ruling, medical educators look to 'holistic review'

Ending health disparities requires full federal government, panel says

Walensky prepares to leave CDC — and Congress — behind

Mitch McConnell episode has important public health takeaway

focus

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Adults seen as increasingly susceptible to measles

Timeline: Special counsel's probe into Trump's handling of classified documents

Behind warning on Apellis’s eye drug lies a conflict of interest

The mammogram wars are not over

Alexander Hamilton and the argument for universal insurance

Wikipedia

focus

focus

hotspot